NRx Pharmaceuticals Gets US FDA Review for Production of ZYESAMI
The company ‘NRx Pharmaceuticals’ has announced the results of the review conducted by the US FDA to the submission of the updated manufacturing information of the ZYESAMI (aviptadil) of the NRx Pharmaceuticals. The completion of the review from the US FDA without any of the imposition of any kind of the clinical hold has been […]
Continue Reading